FDA issued a Warning Letter to Henan Lihua Pharmaceutical Co., Ltd. on 6/12/2018 as a result of this inspection.
483 Henan Lihua Pharmaceutical Dec 2017

483 Henan Lihua Pharmaceutical Dec 2017

Peter Baker FDA$119.00 - Available Now

FDA investigators audited the Henan Lihua Pharmaceutical - Anyang, China facility and issued inspectional observations (via FDA 483) on 14 Dec 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Dec 2017
  • Location: Anyang, China
  • FEI: 3001164052
Add To Cart